MoneyWorks4Me

Kopran - Quaterly Results

03 Feb 2022 Evaluate
Revenue reduced marginally to stand at Rs. 545.73 millions during the quarter ended December 2021. The figure stood at Rs. 565.62 millions during the year-ago period.Net profit of the cmpany stood at Rs. 23.23 millions for the quarter ended December 2021 a decline of -46.29% from Rs. 43.25 millions  in the same quarter last year.Operating profit for the quarter ended December 2021 decreased to 50.34 millions as compared to 78.15 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 545.73 565.62 -3.52 1400.18 1608.68 -12.96 2228.33 1792.91 24.29
Other Income 15.80 25.23 -37.38 59.03 81.82 -27.85 104.14 19.90 423.32
PBIDT 50.34 78.15 -35.59 144.79 313.24 -53.78 406.14 251.66 61.38
Interest 9.75 6.98 39.68 21.56 32.70 -34.07 38.07 59.62 -36.15
PBDT 40.59 71.17 -42.97 123.23 280.54 -56.07 368.07 192.04 91.66
Depreciation 10.98 10.51 4.47 32.63 30.56 6.77 41.03 34.72 18.17
PBT 29.61 60.66 -51.19 90.60 249.98 -63.76 327.04 157.32 107.88
TAX 6.38 17.41 -63.35 20.90 71.65 -70.83 92.33 45.13 104.59
Deferred Tax 1.31 6.64 -80.27 5.07 27.91 -81.83 34.76 17.12 103.04
PAT 23.23 43.25 -46.29 69.70 178.33 -60.92 234.71 112.19 109.21
Equity 432.52 432.49 0.01 432.52 432.49 0.01 432.52 432.49 0.01
PBIDTM(%) 9.22 13.82 -33.24 10.34 19.47 -46.89 18.23 14.04 29.85
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..